Literature DB >> 3943778

Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats.

C Caramelo, D Fernandez-Muñoz, J C Santos, A Blanchart, D Rodriguez-Puyol, J M López-Novoa, L Hernando.   

Abstract

General and splanchnic hemodynamics (radioactive microspheres), renal function, spontaneous and histamine-mediated vasopermeability and albumin distribution space were studied in conscious control and nonascitic cirrhotic rats, before and after a moderate and sustained saline infusion (3% of body weight per 30 min + repletion of urinary losses). In basal conditions, cirrhotic rats showed lower fractional sodium excretion than did control rats (0.09 +/- 0.01 vs. 0.15 +/- 0.01%, p less than 0.005). In addition, cirrhotic animals showed higher cardiac output (161.4 +/- 12.8 ml per min) and lower total peripheral resistance (0.63 +/- 0.05 mm Hg . min per ml) and mean arterial pressure (102.9 +/- 3.9 mm Hg) than did control rats (cardiac output: 89.0 +/- 7.6; total peripheral resistance: 1.31 +/- 0.11; mean arterial pressure: 117.5 +/- 5.11; p less than 0.005). No differences in portal-systemic shunt rate or vasopermeability between both groups were observed. After saline infusion, fractional sodium excretion increased to 4.31 +/- 0.16% in controls but only 2.11 +/- 0.02% in cirrhotic animals. In this group, cardiac output decreased by 49.6 +/- 5.1% whereas mean arterial pressure and total peripheral resistance increased by 7.1 +/- 0.6 and 112 +/- 10%, respectively. In control rats, no significant hemodynamic changes were observed. Blood gases did not change after expansion in any group. Saline infusion induced an increase in histamine-mediated vasopermeability in cirrhotic rats but not in control rats. Also albumin distribution space increased more in cirrhotic than in control animals. Heart weight was higher in cirrhotic rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3943778     DOI: 10.1002/hep.1840060125

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

Review 1.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Echocardiography in the Liver Transplant Patient.

Authors:  Parul Kakar; James Gubitosa; Christine Gerula
Journal:  Curr Cardiol Rep       Date:  2021-07-03       Impact factor: 2.931

3.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

4.  Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.

Authors:  Seyed Ali Gaskari; Hongqun Liu; Leila Moezi; Yang Li; Soon Koo Baik; Samuel S Lee
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

5.  Biliary cirrhosis-induced cardiac abnormality in rats: Interaction between Farnesoid-X-activated receptors and the cardiac uncoupling proteins 2 and 3.

Authors:  Gholamreza Bayat; Seyed Ali Hashemi; Hosein Karim; Parviz Fallah; Keshvad Hedayatyanfard; Mahnaz Bayat; Azadeh Khalili
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

6.  Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels.

Authors:  J M Romeo; C Novo; A Fernández-Cruz; J M Lòpez-Novoa
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

7.  Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis.

Authors:  M Criado-Jiménez; L Rivas-Cabañero; J A Martín-Oterino; J M López-Novoa; A Sánchez-Rodríguez
Journal:  J Mol Med (Berl)       Date:  1995-01       Impact factor: 4.599

Review 8.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy.

Authors:  Csaba Matyas; Katalin Erdelyi; Eszter Trojnar; Suxian Zhao; Zoltan V Varga; Janos Paloczi; Partha Mukhopadhyay; Balazs T Nemeth; György Haskó; Resat Cinar; Robim M Rodrigues; Yeni Ait Ahmed; Bin Gao; Pal Pacher
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.298

Review 10.  Cirrhotic cardiomyopathy.

Authors:  Soon Koo Baik; Tamer R Fouad; Samuel S Lee
Journal:  Orphanet J Rare Dis       Date:  2007-03-27       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.